Literature DB >> 21262925

Differential disposition of chenodeoxycholic acid versus taurocholic acid in response to acute troglitazone exposure in rat hepatocytes.

Tracy L Marion1, Cassandra H Perry, Robert L St Claire, Wei Yue, Kim L R Brouwer.   

Abstract

Inhibition of bile acid (BA) transport may contribute to the hepatotoxicity of troglitazone (TRO), a peroxisome proliferator-activated receptor gamma agonist. Typically, studies use taurocholic acid (TCA) as a model substrate to investigate effects of xenobiotics on BA disposition. However, TRO may differentially affect the transport of individual BAs, potentially causing hepatocyte accumulation of more cytotoxic BAs. The effects of TRO on the disposition of [(14)C]-labeled chenodeoxycholic acid ([(14)C]CDCA), an unconjugated cytotoxic BA, were determined in suspended hepatocytes and sandwich-cultured hepatocytes (SCH) from rats. (E)-3-[[[3-[2-(7-chloro-2-quinolinyl)ethenyl]phenyl][[3-(dimethylamino)-3-oxopropyl]thio]methyl]thio]-propanoic acid (MK571), a multidrug resistance-associated protein (MRP) inhibitor, was included to evaluate involvement of MRPs in CDCA disposition. Accumulation in cells + bile of total [(14)C]CDCA species in SCH was sixfold greater than [(3)H]TCA and unaffected by 1 and 10μM TRO; 100μM TRO and 50μM MK571 ablated biliary excretion and significantly increased intracellular accumulation of total [(14)C]CDCA species. Results were similar in Mrp2-deficient TR(-) rat hepatocytes. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis revealed that taurine- and glycine-conjugated CDCA, in addition to unconjugated CDCA, accumulated in hepatocytes during the 10-min incubation. In suspended rat hepatocytes, initial [(14)C]CDCA uptake was primarily Na(+)-independent, whereas initial [(3)H]TCA uptake was primarily Na(+)-dependent; TRO and MK571 decreased [(14)C]CDCA uptake to a lesser extent than [(3)H]TCA. Unexpectedly, MK571 inhibited Na(+)-taurocholate cotransporting polypeptide and bile salt export pump. Differential effects on uptake and efflux of individual BAs may contribute to TRO hepatotoxicity. Although TCA is the prototypic BA used to investigate the effects of xenobiotics on BA transport, it may not be reflective of other BAs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262925      PMCID: PMC3061484          DOI: 10.1093/toxsci/kfr014

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  46 in total

1.  Differential inhibition of rat and human Na+-dependent taurocholate cotransporting polypeptide (NTCP/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity.

Authors:  Elaine M Leslie; Paul B Watkins; Richard B Kim; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2007-03-20       Impact factor: 4.030

2.  Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.

Authors:  C Funk; M Pantze; L Jehle; C Ponelle; G Scheuermann; M Lazendic; R Gasser
Journal:  Toxicology       Date:  2001-10-05       Impact factor: 4.221

Review 3.  Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance.

Authors:  J König; A T Nies; Y Cui; I Leier; D Keppler
Journal:  Biochim Biophys Acta       Date:  1999-12-06

Review 4.  Hepatic transport of bile salts.

Authors:  G A Kullak-Ublick; B Stieger; B Hagenbuch; P J Meier
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

5.  Tissue distribution and induction of human multidrug resistant protein 3.

Authors:  George L Scheffer; Marcel Kool; Marcel de Haas; J Marleen L de Vree; Adriana C L M Pijnenborg; Diederik K Bosman; Ronald P J Oude Elferink; Paul van der Valk; Piet Borst; Rik J Scheper
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

6.  Effect of thiazolidinediones on bile acid transport in rat liver.

Authors:  Kris L Snow; Richard H Moseley
Journal:  Life Sci       Date:  2006-11-10       Impact factor: 5.037

Review 7.  Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review.

Authors:  Yasuhiro Masubuchi
Journal:  Drug Metab Pharmacokinet       Date:  2006-10       Impact factor: 3.614

8.  Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.

Authors:  Hiroaki Yamaguchi; Masahiro Okada; Shou Akitaya; Hiroshi Ohara; Tsuyoshi Mikkaichi; Haruna Ishikawa; Mayumi Sato; Masaki Matsuura; Toshihide Saga; Michiaki Unno; Takaaki Abe; Nariyasu Mano; Takanori Hishinuma; Junichi Goto
Journal:  J Lipid Res       Date:  2006-03-13       Impact factor: 5.922

9.  Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method.

Authors:  Debora Tagliacozzi; Alessia F Mozzi; Bruno Casetta; Pierfrancesco Bertucci; Sergio Bernardini; Carmine Di Ilio; Andrea Urbani; Giorgio Federici
Journal:  Clin Chem Lab Med       Date:  2003-12       Impact factor: 3.694

10.  Transport characteristics of three fluorescent conjugated bile acid analogs in isolated rat hepatocytes and couplets.

Authors:  L M Maglova; A M Jackson; X J Meng; M W Carruth; C D Schteingart; H T Ton-Nu; A F Hofmann; S A Weinman
Journal:  Hepatology       Date:  1995-08       Impact factor: 17.425

View more
  5 in total

Review 1.  An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.

Authors:  Kyunghee Yang; Kathleen Köck; Alexander Sedykh; Alexander Tropsha; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2013-05-07       Impact factor: 3.534

2.  Endogenous bile acid disposition in rat and human sandwich-cultured hepatocytes.

Authors:  Tracy L Marion; Cassandra H Perry; Robert L St Claire; Kim L R Brouwer
Journal:  Toxicol Appl Pharmacol       Date:  2012-02-11       Impact factor: 4.219

Review 3.  Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models.

Authors:  Richard J Weaver; Eric A Blomme; Amy E Chadwick; Ian M Copple; Helga H J Gerets; Christopher E Goldring; Andre Guillouzo; Philip G Hewitt; Magnus Ingelman-Sundberg; Klaus Gjervig Jensen; Satu Juhila; Ursula Klingmüller; Gilles Labbe; Michael J Liguori; Cerys A Lovatt; Paul Morgan; Dean J Naisbitt; Raymond H H Pieters; Jan Snoeys; Bob van de Water; Dominic P Williams; B Kevin Park
Journal:  Nat Rev Drug Discov       Date:  2019-11-20       Impact factor: 84.694

4.  Combination lopinavir and ritonavir alter exogenous and endogenous bile acid disposition in sandwich-cultured rat hepatocytes.

Authors:  LaToya M Griffin; Paul B Watkins; Cassandra H Perry; Robert L St Claire; Kim L R Brouwer
Journal:  Drug Metab Dispos       Date:  2012-10-22       Impact factor: 3.922

5.  PPAR Medicines and Human Disease: The ABCs of It All.

Authors:  Anthony J Apostoli; Christopher J B Nicol
Journal:  PPAR Res       Date:  2012-08-07       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.